NCT02359058 - A Study of Ramucirumab Combination Therapy in Japanese Participants Who Have Advanced Stomach Cancer | Biotech Hunter

Enrollment

18

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

November 30, 2016

Conditions

Stomach Neoplasms

Interventions

DRUG

Ramucirumab

Administered IV

DRUG

Capecitabine

Administered orally

DRUG

Cisplatin

Administered IV

DRUG

S-1

Administered orally

DRUG

Oxaliplatin

Administered IV

Trial Locations (4)

464-8681

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician., Aichi

277-8577

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician., Chiba

791-0280

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician., Ehime

565-0871

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician, Osaka